Pharmaceutical Imports in Central America Al June 30th, 2021  

CentralAmericaDataINFORMACIÓN DE MERCADOS

Complete el formulario, en breve nos comunicaremos con usted:

Your message has been sent. We will contact you shortly.

Name*

Last Name*

Email:*

Telephone (Country):*

Company:*

Title:*

Size of the Company:* Choose one... Less than 100 employees Between 100 and 500 Between 500 and 2500 More than 2500

Industry:* -None- Agro Alimentos y bebidas Construcción e infraestructura Banca y finanzas Farmacéutica y salud Servicios Retail Automotriz Energía y minería Química y plástico Bienes Raíces Educación Bienes de consumo Industria y manufactura Transporte y logística Telecomunicaciones Administración pública

Yes, I want to receive a call from a salesperson*

Comments:*  

this site is protected by reCAPTCHA and Google's privacy policy and terms of service.

Need assistance? Contact us

(506) 4001-6423

CentralAmericaData is the leading B2B market research company in Central America. We specialize in compiling, validating and analyzing data from the economic activities in Central American and South American countries, along with Mexico. We provide our clients and companies with presence in the region relevant information to define business strategies and make adequate decisions. Learn more about our services here

2008 - 2022 © CentralAmericaData Todos los derechos reservados

Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]

Explore the data in the interactive display.

Costa Rican Companies: Main Buyers
From January to September 2020 the main buyer of pharmaceutical products in Central America was Costa Rica, with $633 million, followed by Guatemala, with $503 million, Panama, with $464 million, Honduras, with $390 million, El Salvador, with $339 million and Nicaragua, with $296 million.

Regarding the year-on-year variation of purchases abroad, for the period in question, Nicaragua reported a 10% increase, followed by Costa Rica, with 4%, and Guatemala and Honduras, with 3% each.

El Salvador and Panama were the markets in the region that recorded negative variations, which amounted to -2% and -12%, in that order.

Slight Decline in Regional Business
Between the first nine months of 2019 and the same period of 2020, the imported value of pharmaceutical products in Central America registered a slight positive variation, going from $2,614 million to $2,625 million.

For the periods in question, regional purchases from Spain increased by 13%, from $124 million to $140 million, and imports from Mexico increased by 2%, from $220 million to $226 million.

Germany and Mexico: Main Suppliers
Between January and September of last year, 9% of the value of imports from Central America came from Germany, 9% from Mexico, 8% from the USA, 5% from Spain, 5% from India and 4% from Switzerland.

Germany is the country of origin of Central American imports that has grown the most in the period in question in recent years, since in 2012 it represented 4% of the total value purchased, and in 2020 it rose to 9%.

Note: For this report, prepared by CentralAmericaData, SIECA data were used.

Do you need to understand the new reality of the pharmaceutical market? Contact Us

Your message has been sent. We will contact you shortly.

Name*

Last Name*

Email:*

Telephone (Country):*

Company:*

Title:*

Size of the Company:* Choose one... Less than 100 employees Between 100 and 500 Between 500 and 2500 More than 2500

Industry:* -None- Agro Alimentos y bebidas Construcción e infraestructura Banca y finanzas Farmacéutica y salud Servicios Retail Automotriz Energía y minería Química y plástico Bienes Raíces Educación Bienes de consumo Industria y manufactura Transporte y logística Telecomunicaciones Administración pública

Yes, I want to receive a call from a salesperson*

Comments:*  

this site is protected by reCAPTCHA and Google's privacy policy and terms of service.

Need assistance? Contact us

(506) 4001-6423

More on this topic

Pharmaceuticals: How do Markets Behave?

December 2020

Nicaragua, Costa Rica and Guatemala are the Central American markets that during the first half of 2020 and in year-on-year terms, increased their imports of pharmaceutical products.

Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]

Pharmaceuticals: Which Markets are Growing the Most?

February 2020

From January to September 2019, pharmaceutical product imports in Central America totaled $2.614 million, 8% more than in the same period in 2018, with El Salvador, Panama and Costa Rica being the markets where purchases increased the most.

Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption "Click to interact with graphics"]

Pharmaceutical Market Figures in Costa Rica

July 2018

From January to March of this year, companies in Costa Rica imported $170 million worth of pharmaceutical products, 7% less than in the same period in 2017, and 30% came from the USA and Germany.

Figures from the information system on the Pharmaceutical Market in Costa Rica, compiled by the Business Intelligence Unit at CentralAmericaData: [GRAFICA caption = "Click to interact with graph"]

Pharmaceutical Products: Central American Market Figures

June 2018

In 2017, Central American countries imported $3.171 billion worth of pharmaceutical products, of which 44% were purchased by companies in Costa Rica and Guatemala.

Figures from the information system on the Pharmaceutical Products Market in Central America, compiled by the Business Intelligence Unit at CentralAmericaData: [GRAFICA caption = "Click to interact with graph"]